# RethinQ Study - Evaluating Pacing in Heart Failure Patients

> **NCT00132977** · PHASE3 · COMPLETED · sponsor: **Abbott Medical Devices** · enrollment: 250 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DEVICE:** Cardiac Resynchronization Therapy

## Key facts

- **NCT ID:** NCT00132977
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** 2007-07
- **Final completion:** 2007-07
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2019-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00132977

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00132977, "RethinQ Study - Evaluating Pacing in Heart Failure Patients". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00132977. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*